pan-mutant pi3kα inhibitor
pan-mutant pi3kα inhibitor: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| OnKure Therapeutics, Inc. (OKUR) | Preclinical |
Get deeper analysis on pan-mutant pi3kα inhibitor
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis